DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 01 · Volume 38 · Januar 2005 DOI: 10.1055/s-002-3854

A joint meeting of the AGNP-TDM Group, of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) (Association of Neuropsychopharmacology and Pharmacopsychiatry) and the SGAMSP (Schweizerische Gesellschaft für Arzneimittelsicherheit in der Psychiatrie/Société suisse de pharmacovigilance en psychiatrie/Swiss Society of Pharmacovigilance in Psychiatry) in collaboration with the AMSP e.V., Germany (German Society of Pharmacovigilance in Psychiatry) and ÖAMSP (Austrian Society of Pharmacovigilance in Psychiatry)
International Meeting on Pharmacovigilance in Psychiatry, Therapeutic Drug Monitoring and Pharmacogenetics of Psychotropic Drugs
Lausanne, Switzerland, September 1–3, 2004

Pierre Baumann, Prilly-Lausanne, Switzerland, and Josef Aldenhoff, Kiel, Germany
Abstracts (HTML) Autorenliste

Original Paper

Original Paper

  • 1
    Bücheler, R.; Gleiter, C. H.; Schwoerer, P.; Gaertner, I.:

    Use of Nonprohibited Hallucinogenic Plants: Increasing Relevance for Public health?

  • 6
    Kluge, M.; Wehmeier, P. M.; Dittmann, R. W.; Langer, F.; Czekalla, J.; Lehmann, M.; Keßler, F. H.; Beyenburg, S.; Naber, D.:

    A Simple Switching Strategy for Inadequately Treated Patients with Schizophrenia to Olanzapine: Changes in Psychopathology and Subjective Well-being

  • 13
    Wehmeier, P. M.; Kluge, M.; Maras, A.; Riemann, D.; Berger, M.; Kohnen, R.; Dittmann, R. W.; Gattaz, W. F.:

    Fluoxetine Versus Trimipramine in the Treatment of Depression in Geriatric Patients

  • 17
    Nakajima, M.; Terao, T.; Iwata, N.; Nakamura, J.:

    Switching Female Schizophrenic Patients to Quetiapine from Conventional Antipsychotic Drugs: Effects on Hyperprolactinemia

  • 24
    Kronenberg, G.; Berger, P.; Tauber, R. F.; Bandelow, B.; Henkel, V.; Heuser, I.:

    Randomized, Double-Blind Study of SR142801 (Osanetant). A Novel Neurokinin-3 (NK3) Receptor Antagonist in Panic Disorder with Pre- and Posttreatment Cholecystokinin Tetrapeptide (CCK-4) Challenges

  • 30
    Otsubo, T.; Akimoto, Y.; Yamada, H.; Koda, R.; Aoyama, H.; Tanaka, K.; Mimura, M.; Nakagome, K.; Kamijima, K.:

    A Comparative Study of the Efficacy and Safety Profiles Between Fluvoxamine and Nortriptyline in Japanese Patients with Major Depression

    • Review

  • 20
    Grootens, K. P.; Verkes, R. J.:

    Emerging Evidence for the Use of Atypical Antipsychotics in Borderline Personality Disorder

    • Letter

  • 36
    Baumgart, U.; Schmid, R.; Spießl, H.:

    Olanzapine-Induced Acute Rhabdomyolysis

  • 38
    Croissant, B.; Hermann, D.; Olbrich, R.:

    Reduction of Side Effects by Combining Clozapine with Amisulpride: Case Report and Short Review of Clozapine-Induced Hypersalivation

  • 39
    Kämpf, P.; Agelink, M. W.; Naber, D.:

    Augmentation of Clozapine with Amisulpride: A Promising Therapeutic Approach to Refractory Schizophrenic Symptoms